跳至主要内容
临床试验/NCT02432118
NCT02432118撤回不适用

A Feasibility Study of Radiofrequency Identification (RFID) Localization of Breast Lesions

Stanford University0 个研究点开始时间: 2015年5月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
主要终点
Localization success, defined as the surgical target visualized in the removed specimen AND the RFID tag removed from the patient's breast

研究概览

简要总结

This pilot clinical trial studies the use of the radiofrequency-guided localization in patients with abnormal breast tissue undergoing lumpectomy (a type of breast-sparing surgery). The radiofrequency identification localization system consists of an implantable radiofrequency identification tag and a hand-held radiofrequency reader to mark abnormal breast tissue before surgery and later surgically retrieve them. Radiofrequency-guided localization may make it easier to find and remove abnormal breast tissue during lumpectomy.

详细描述

PRIMARY OBJECTIVES:

I. To obtain human clinical data in order to demonstrate that the Radiofrequency Identification (RFID) Localization System performs as intended as a localization device for marking and retrieving a surgical target in the breast.

SECONDARY OBJECTIVES:

I. To solicit feedback from the radiologists and surgeons regarding the process and use of the RFID system.

OUTLINE:

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Have had stereotactic or ultrasound-guided biopsy with marker placement
  • Have a lesion or biopsy marker that is visible under ultrasound
  • Have a surgical target =< 6 cm from the skin when lying supine
  • Have a discreet surgical target
  • Have a lesion in which the center/focal area is defined
  • Have the ability to understand and the willingness to sign a written informed consent document
  • Eastern Cooperative Oncology Group (ECOG)/Karnofsky performance status will not be used as an inclusion criterion
  • Ability to understand and the willingness to sign a written informed consent document

排除标准

  • Require more than one localization needle for localization of the surgical target (bracket localization)
  • Have undergone previous open surgical biopsy, lumpectomy, or mastectomy in the operative breast
  • Have a prosthesis/implant in the operative breast
  • Have a cardiac pacemaker or defibrillator device
  • Be contraindicated for surgery
  • Be pregnant

结局指标

主要结局

Localization success, defined as the surgical target visualized in the removed specimen AND the RFID tag removed from the patient's breast

时间窗: At time of surgery

Will be summarized using descriptive statistics, including total numbers, percentages, means, and proportions.

次要结局

  • Feedback solicited from the radiologist and surgeon(Up to 12 months after lumpectomy)

研究者

申办方类型
Other
责任方
Sponsor

相似试验

Radiofrequency-Guided Localization in Patients With... | 临床试验